Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus
Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus
The aim of this study is to investigate the continued usage of standard diabetes medications in the post operative period following bariatric surgery to determine whether this approach may improve long term diabetes control. At present, the standard of treatment in patients with type 2 diabetes is that all medication is stopped in the immediate postoperative period and only re-started if symptoms of diabetes re-emerge. Although a large proportion of patients with diabetes will initially go in to remission, 80% experience relapse within five years. This study is needed to determine whether continuing medications is not only safe but will improve long term outcomes for patients with diabetes.
Inclusion Criteria:
Exclusion Criteria:
a.miras@nhs.net: +44 (0)20 8383 3242